VOLITIONRX LTD (VNRX) › Cash & EquivalentsVOLITIONRX LTD (VNRX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2010-12-31: $47.5K2011-12-31: $347.9K2012-12-31: $376.4K2014-12-31: $2.14M2015-12-31: $5.92M2016-12-31: $21.68M2017-12-31: $10.12M2018-12-31: $13.43M2019-12-31: $16.97M2020-12-31: $19.44M2021-12-31: $20.58M2022-12-31: $10.87M2023-12-31: $20.73M2024-12-31: $3.26M2025-12-31: $1.12M$1.12M2010-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$1.12M-65.8%2026-03-31Balance as of period end2024-12-31$3.26M-84.3%2026-03-31Balance as of period end2023-12-31$20.73M+90.8%2025-03-31Balance as of period end2022-12-31$10.87M-47.2%2024-03-25Balance as of period end2021-12-31$20.58M+5.8%2023-03-15Balance as of period end2020-12-31$19.44M+14.6%2022-03-30Balance as of period end2019-12-31$16.97M+26.4%2022-03-30Balance as of period end2018-12-31$13.43M+32.7%2021-03-22Balance as of period end2017-12-31$10.12M-53.3%2019-03-13Balance as of period end2016-12-31$21.68M+266.4%2019-03-13Balance as of period end2015-12-31$5.92M+176.6%2018-03-01Balance as of period end2014-12-31$2.14M—2017-03-10Balance as of period end2012-12-31$376.4K+8.2%2013-04-01Balance as of period end2011-12-31$347.9K+632.7%2013-04-01Balance as of period end2010-12-31$47.5K—2013-04-01Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)